The Unseen Capital Health Fund LP, a newly-formed venture fund created by racially diverse and historically unrepresented business leaders was formed to identify, fund, and support underrepresented founders of early-stage healthcare companies and those upstarts developing solutions for marginalized communities. Now major American pharmaceutical company Eli Lilly (NYSE: LLY) announced a $30 million investment into the fund representing just one component of the Indianapolis-based company’s racial justice efforts, injecting mission-aligned capital for the fund. Now an active investing fund, Unseen Capital now closes in on the $100 million fund milestone thanks to the Lilly deal. This deal represents the idea that institutional capital (whether it be venture, private equity, corporate, etc.) now sets its sights on the “underdeveloped” spheres or zones of the U.S. economy to not only generate new value but also lift underrepresented groups up along the way.
TrialSite offers a little clarity on what this fund is, why it exists, what it will be used for and who is behind it.
Who is behind this fund?
The fund appears to have been launched by a group including Kayode Owens, who e...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).